The medical devices manufacturer, PhotoMedex has proposed a co-pay reimbursement program targeted at children to provide them with better access to XTRAC psoriasis treatment. The offer will coincide with the World Psoriasis Day, to be observed on 29th October.
Photomedex’s painless XTRAC excimer laser has been designed to provide safe, efficient and targeted phototherapy treatment, which produces long lasting results. Other treatment options for the disease that include full-body UVB, topical steroids, biologics and systemic medications are known to have side effects. The XTRAC excimer laser is safe for children, since it targets only the affected areas with phototherapy light. It is an FDA-cleared, clinically-proven dermatology excimer laser.
Psoriasis is a disease that affects all ethnicities, races, genders and ages. Over 125 million patients suffer from psoriatic arthritis or psoriasis, majority of the affected being children. Yearly, over 20,000 children are diagnosed with the diseases in USA alone. A recent study concluded that children affected with psoriasis often receive inconsistent care and the treatment depends on whether they consult a dermatologist, internist or a pediatrician, each of whom have a different treatment approach. With psoriasis and the dry, itchy red skin along with other symptoms, it is important to see a dermatologist who can offer the latest and most effective treatment solution for children.
The dermatologist at Michigan’s Oakland Aesthetic Dermatology, Dr Barry Auster stated that the treatment options for children are more limited because of the dangers and side effects associated with them. The XTRAC treatment option is a safer, efficient method that provides longer lasting results without steroids and messy creams. Dr Auster concluded by saying that the co-pay offer offers help and relief to the children who did not have access to the treatment because of the costs.
Source: http://www.XTRACLaser.com/